Skip to main content

Compugen Ltd

CGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001119774

In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Compugen Ltd changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CGEN: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders65170+6
Shares12.0M83.8K12.2M+283.0K (+2.4%)
Value$21.7M$151.7K$18.6M−$2.90M (−13.5%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Compugen Ltd at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CGEN in Q4 2024
InstitutionSharesValue% of portfolio
Raymond James Financial Inc67,041$102.6K0.00%
Jane Street Group, LLC53,030$81.1K0.00%
Commonwealth Equity Services, LLC20,791$32.0K0.00%
HRT Financial LP20,034$30.0K0.00%
Cambridge Investment Research Advisors, Inc.11,525$18.0K0.00%
Cubist Systematic Strategies, LLC11,054$16.9K0.00%
Simplex Trading, LLC5,531$8.00K0.00%
R Squared Ltd2,670$4.08K0.00%
Eastern Bank2,000$3.06K0.00%
Citigroup Inc922$1.41K0.00%
Sound Income Strategies, LLC500$7650.00%
SBI Securities Co., Ltd.401$6140.00%
Koesten, Hirschmann & Crabtree, INC.100$1530.00%
Modus Advisors, LLC28$430.00%

Sold out (8)

Institutions that held Compugen Ltd at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CGEN in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
ARK Investment Management LLCSuperinvestorARK Invest1,092,183$2.00M
Hillsdale Investment Management Inc.38,480$69.6K
Invesco Ltd.21,051$38.1K
Cetera Investment Advisers12,980$23.5K
Ieq Capital, LLC10,000$18.1K
Beverly Hills Private Wealth, LLC10,000$18.1K
Ronald Blue Trust, Inc.5,663$9.51K
GWM Advisors LLC300$543

Not filed for Q4 2024 yet (1)

Institutions that held Compugen Ltd at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGEN in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James & Associates83,825$151.7K